#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	19264	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2536	933.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1653	1653	C	1216	C	1216	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32214	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4062	988.3	0	.	n	.	0	T695C	SNP	695	695	T	1306	1306	C	1202	C,T,G	1197,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32214	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4062	988.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1948	1948	A	1301	A,T,G,C	1296,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32214	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4062	988.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2582	2582	C	1187	C,T,G,A	1181,2,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32214	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4062	988.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2656	2656	A	1081	A,T,C,G	1077,2,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32214	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4062	988.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3208	3208	C	1155	C,G,T,A	1150,2,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32214	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4062	988.3	0	HET	.	.	.	C2402T,G	.	2402	2402	C	3013	3013	C	1147	C,T,G	861,284,2	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2918	folP	855	855	100.0	folP.l15.c30.ctg.1	1874	193.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1174	1176	AGC	270;271;270	A,G;G;C,T	269,1;271;269,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6762	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3870	217.8	1	SNP	p	S91F	1	.	.	271	273	TTC	826	828	TTC	254;255;255	T;T,A;C,G	254;254,1;252,3	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6762	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3870	217.8	1	SNP	p	G95N	0	.	.	283	285	GGC	838	840	GGC	267;266;270	G,A;G,T,C;C,G,A	265,2;264,1,1;268,1,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6762	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3870	217.8	1	SNP	p	D95G	1	.	.	283	285	GGC	838	840	GGC	267;266;270	G,A;G,T,C;C,G,A	265,2;264,1,1;268,1,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	2498	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1807	172.3	1	SNP	p	G45D	0	.	.	133	135	GGC	729	731	GGC	296;292;292	G,T,A;G,T,A;C	294,1,1;290,1,1;292	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1418	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1530	115.7	0	.	n	.	0	A197.	DEL	197	197	A	852	852	A	268	A	268	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6268	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3460	225.7	1	SNP	p	D86N	0	.	.	256	258	GAC	812	814	GAC	306;309;309	G;A;C,T	306;309;308,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6268	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3460	225.7	1	SNP	p	R87I	0	.	.	259	261	CGT	815	817	CGT	306;308;311	C;G,A;T	306;306,2;311	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6268	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3460	225.7	1	SNP	p	R87W	0	.	.	259	261	CGT	815	817	CGT	306;308;311	C;G,A;T	306;306,2;311	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6268	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3460	225.7	1	SNP	p	S87R	1	.	.	259	261	CGT	815	817	CGT	306;308;311	C;G,A;T	306;306,2;311	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6268	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3460	225.7	1	SNP	p	S88P	0	.	.	262	264	TCC	818	820	TCC	316;313;310	T,G;C;C	315,1;313;310	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5258	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3227	203.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1813	1815	GGC	299;301;298	G,C;G;C,T	298,1;301;297,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	5200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2972	218.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1556	1558	GCA	320;321;319	G,T;C;A	319,1;321;319	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2972	218.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1559	1561	ATC	319;319;317	A,T;T;C,A	318,1;319;316,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2972	218.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1571	1573	GTG	311;311;309	G;T;G	311;311;309	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2972	218.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1571	1573	GTG	311;311;309	G;T;G	311;311;309	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2972	218.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2075	2077	ACC	302;299;299	A;C;C	302;299;299	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2972	218.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2129	2131	GCG	284;285;287	G;C,G;G,T	284;283,2;286,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2972	218.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2129	2131	GCG	284;285;287	G;C,G;G,T	284;283,2;286,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2972	218.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2252	2254	AGC	291;292;293	A;G;C,G	291;292;292,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2972	218.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2261	2263	GGC	289;288;288	G;G,T;C	289;287,1;288	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5200	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2972	218.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2279	2281	CCG	295;297;297	C;C;G	295;297;297	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7136	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3506	253.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1833	1835	CCG	281;285;284	C,T;C;G	279,1;285;284	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3142	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2569	152.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	903	903	C	240	C	240	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	326	porB1a	984	156	93.59	porB1a.l15.c17.ctg.2	156	58.5	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	19;20;22	T;T;A	19;20;22	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	326	porB1a	984	156	93.59	porB1a.l15.c17.ctg.2	156	58.5	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	73;73;73	C;A;T	73;73;73	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	326	porB1a	984	156	93.59	porB1a.l15.c17.ctg.2	156	58.5	0	.	p	.	0	D274G	NONSYN	820	822	GAT	62	64	GGT	73;73;73	G;G;T	73;73;73	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	326	porB1a	984	156	93.59	porB1a.l15.c17.ctg.2	156	58.5	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	73;73;73	T;A;C	73;73;73	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	326	porB1a	984	100	94.0	porB1a.l15.c17.ctg.4	181	53.2	0	.	p	.	0	M18T	NONSYN	52	54	ATG	132	134	ACG	65;64;60	A,G;C;G	64,1;64;60	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	326	porB1a	984	100	94.0	porB1a.l15.c17.ctg.4	181	53.2	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	174	176	CAA	20;17;15	C;A;A	20;17;15	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3662	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1831	246.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	538	540	GAA	327;325;325	G;A,C;A,G	327;324,1;324,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3662	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1831	246.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	826	828	GAT	297;299;299	G;A;T	296;298;298	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3662	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1831	246.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	949	951	TCA	330;330;328	T;C;A	330;330;328	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3662	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1831	246.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1078	1080	GTC	329;327;325	G,C;T;C,G	327,2;327;324,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3662	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1831	246.2	0	.	p	.	0	F222L	NONSYN	664	666	TTT	1090	1092	CTT	335;334;334	C;T;T	335;333;334	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3662	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1831	246.2	0	.	p	.	0	S295G	NONSYN	883	885	AGT	1309	1311	GGT	284;287;283	G,T;G;T	283,1;287;283	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3662	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1831	246.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1408	1410	GCA	289;289;288	G,A;C;A,T	287,2;289;287,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3662	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1831	246.2	1	SNP	p	G120K	1	.	.	358	360	AAG	784	786	AAG	282;281;285	A,G;A,C;G	281,1;280,1;285	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3662	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1831	246.2	1	SNP	p	A121D	1	.	.	361	363	GAC	787	789	GAC	287;292;294	G,T;A,T;C,T	285,1;291,1;293,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3662	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1831	246.2	1	SNP	p	D121N	0	.	.	361	363	GAC	787	789	GAC	287;292;294	G,T;A,T;C,T	285,1;291,1;293,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11914	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5307	279.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1874	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1424	163.8	1	SNP	p	V57M	1	.	.	169	171	ATG	758	760	ATG	332;334;332	A;T;G	332;334;332	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
